| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10811 | 2021 |
| Long-term cultures of bone marrow–derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation GV Røsland, A Svendsen, A Torsvik, E Sobala, E McCormack, ... Cancer research 69 (13), 5331-5339, 2009 | 811 | 2009 |
| CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells J Wang, PØ Sakariassen, O Tsinkalovsky, H Immervoll, SO Bøe, ... International journal of cancer 122 (4), 761-768, 2008 | 731 | 2008 |
| Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track–letter A Torsvik, GV Røsland, A Svendsen, A Molven, H Immervoll, ... Cancer research 70 (15), 6393-6396, 2010 | 360 | 2010 |
| The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling M Chekenya, C Krakstad, A Svendsen, IA Netland, V Staalesen, ... Oncogene 27 (39), 5182-5194, 2008 | 189 | 2008 |
| U‐251 revisited: genetic drift and phenotypic consequences of long‐term cultures of glioblastoma cells A Torsvik, D Stieber, PØ Enger, A Golebiewska, A Molven, A Svendsen, ... Cancer medicine 3 (4), 812-824, 2014 | 184 | 2014 |
| Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma A Svendsen, JJC Verhoeff, H Immervoll, JC Brøgger, J Kmiecik, A Poli, ... Acta neuropathologica 122, 495-510, 2011 | 154 | 2011 |
| Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma J Wang, A Svendsen, J Kmiecik, H Immervoll, KO Skaftnesmo, ... PloS one 6 (7), e23062, 2011 | 142 | 2011 |
| Glioma cell populations grouped by different cell type markers drive brain tumor growth L Prestegarden, A Svendsen, J Wang, L Sleire, KO Skaftnesmo, ... Cancer research 70 (11), 4274-4279, 2010 | 109 | 2010 |
| Novel points of attack for targeted cancer therapy GV Røsland, AST Engelsen Basic & clinical pharmacology & toxicology 116 (1), 9-18, 2015 | 87 | 2015 |
| A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions SP Niclou, C Danzeisen, HP Eikesdal, H Wiig, NHC Brons, AMF Poli, ... The FASEB Journal 22 (9), 3120, 2008 | 76 | 2008 |
| AXL targeting abrogates autophagic flux and induces immunogenic cell death in drug-resistant cancer cells ML Lotsberg, K Wnuk-Lipinska, S Terry, TZ Tan, N Lu, L Trachsel-Moncho, ... Journal of Thoracic Oncology 15 (6), 973-999, 2020 | 75 | 2020 |
| NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival A Gras Navarro, J Kmiecik, L Leiss, M Zelkowski, A Engelsen, Ø Bruserud, ... The Journal of Immunology 193 (12), 6192-6206, 2014 | 63 | 2014 |
| AXL targeting overcomes human lung cancer cell resistance to NK-and CTL-mediated cytotoxicity S Terry, A Abdou, AST Engelsen, S Buart, P Dessen, S Corgnac, ... Cancer immunology research 7 (11), 1789-1802, 2019 | 59 | 2019 |
| Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC GV Røsland, SE Dyrstad, D Tusubira, R Helwa, TZ Tan, ML Lotsberg, ... Cancer & Metabolism 7, 1-18, 2019 | 58 | 2019 |
| Guidelines for the use and interpretation of assays for monitoring autophagy 1 D Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... Autophagy 17 (1), 1-382, 2021 | 57 | 2021 |
| Role of hypoxia-mediated autophagy in tumor cell death and survival RF Zaarour, B Azakir, EY Hajam, H Nawafleh, NA Zeinelabdin, ... Cancers 13 (3), 533, 2021 | 52 | 2021 |
| Hypoxia-driven intratumor heterogeneity and immune evasion S Terry, AST Engelsen, S Buart, WS Elsayed, GH Venkatesh, S Chouaib Cancer letters 492, 1-10, 2020 | 47 | 2020 |
| Oxygen-dependent regulation of tumor growth and metastasis in human breast cancer xenografts K Yttersian Sletta, MK Tveitarås, N Lu, AST Engelsen, RK Reed, ... PloS one 12 (8), e0183254, 2017 | 44 | 2017 |
| Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival MA Rahman, A Gras Navarro, J Brekke, A Engelsen, C Bindesbøll, ... British journal of cancer 121 (7), 545-555, 2019 | 38 | 2019 |
per lonningUniversity of Bergen, Norway在 helse-bergen.no 的电子邮件经过验证
